Guidelines Updated on Managing Glucocorticoid-Induced Osteoporosis — Physician’s First Watch

Medical News |
June 9, 2017

Guidelines Updated on Managing Glucocorticoid-Induced Osteoporosis

By Amy Orciari Herman

Edited by André Sofair, MD, MPH, and William E. Chavey, MD, MS

The American College of Rheumatology has issued updated guidance on managing glucocorticoid-induced osteoporosis in adults and children. Among the recommendations:

  • For all patients, fracture risk should be assessed within 6 months (or sooner) after starting long-term glucocorticoid treatment. The assessment should include details on the glucocorticoid dosage, fracture history, bone mineral density, comorbidities, height and weight measurement, and for adults aged 40 and older, use of the FRAX tool.

  • Fracture risk should be reassessed every 12 months during treatment.

  • All patients should optimize their calcium and vitamin D intake and make lifestyle changes consistent with good bone health (e.g., stop smoking, exercise regularly).

Recommendations on antiresorptive medications are given based on fracture risk. The guidance, freely available in Arthritis and Rheumatism, also includes recommendations for specific populations (e.g., women of childbearing potential, organ transplant recipients).

Reader Comments (1)

JABER ALKHABOURI Physician, Neurology, khawal hospital

execellet

Your Comment

(will not be published)

Filtered HTML

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Do you have any conflict of interest to disclose?
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

* Required

Reader comments are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.